January 2026 Prescription Drug Affordability Board Meeting

Meeting Canceled

Due to the declared state of emergency and the closing of State offices and facilities, the Prescription Drug Affordability Board meeting scheduled for Monday, January 26, 2026 is cancel​ed. When the meeting is rescheduled, the Board will provide advance notice of the rescheduled meeting date on the website and through the listserv.

• Date and time: January 26th, 2026 2:00 pm

About

The Maryland Prescription Drug Affordability Board invites you to attend the January Board Meeting, scheduled for Monday, January 26, 2026 at 2:00 PM. The meeting will be held remotely. Part of the meeting may be conducted in closed session. 

Public Comment

The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected]​ no later than the close of business on Wednesday, January 21, 2026, and provide:

1. Your name
2. Your address
3. The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.

Written Comment

The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]​​​. Please submit any written comments, concerning this agenda no later than the close of business on Wednesday, January 21, 2026. Please utilize the subject line “January 2026 Board Comments.”

Agenda and Meeting Materials

• Agenda - PDF - 160.93 KB
• Policy Review Process- Staff Preliminary Recommendations- Presentation (Revised 1/16/26) - PDF - 1.35 MB
• Ozempic: Upper Payment Limit Framework (1/16/2026) - PDF - 312.43 KB
• Ozempic: Upper Payment Limit Framework- Presentation - PDF - 295.19 KB
• Trulicity: Up​per Payment Limit Framework (1/16/2026) - PDF - 159.42 KB​​
• Trulicity: Upper Payment Limit Framework- Presentation​ - PDF - 155.65 KB
• Written comment packet - PDF - 4.17 MB

Comments Received from the following:

• AARP
• Diabetes Patient Advocacy Coalition
• Community Access National Network (CANN)
• EACH/PIC Coalition
• Eli Lilly
• Let My Doctors Decide Action Network
• National Infusion Center Association and Infusion Accession Foundation
• Value of Care Coalition